IIA
RMD icon

ICW Investment Advisors’s ResMed RMD Stock Holding History

ICW Investment Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.33M Sell
11,969
-136
-1% -$28.2K 0.82% 46
2026
Q1 		$2.72M Buy
12,105
+564
+5% +$141K 0.98% 37
2025
Q4 		$2.78M Sell
11,541
-353
-3% -$90.3K 1.01% 35
2025
Q3 		$3.26M Buy
11,894
+370
+3% +$101K 1.17% 27
2025
Q2 		$2.97M Buy
11,524
+130
+1% +$31K 1.17% 25
2025
Q1 		$2.55M Buy
11,394
+41
+0.4% +$9.57K 1.04% 31
2024
Q4 		$2.6M Buy
11,353
+77
+0.7% +$18.5K 1.08% 29
2024
Q3 		$2.75M Buy
11,276
+75
+0.7% +$16.8K 1.15% 25
2024
Q2 		$2.14M Sell
11,201
-240
-2% -$48.7K 0.97% 34
2024
Q1 		$2.27M Buy
11,441
+138
+1% +$25.3K 1.01% 32
2023
Q4 		$1.94M Buy
11,303
+249
+2% +$38.3K 0.95% 38
2023
Q3 		$1.63M Buy
11,054
+345
+3% +$62.4K 0.88% 41
2023
Q2 		$2.34M Buy
10,709
+141
+1% +$31.4K 1.26% 23
2023
Q1 		$2.31M Buy
10,568
+194
+2% +$42.1K 1.31% 19
2022
Q4 		$2.16M Sell
10,374
-101
-1% -$22.2K 1.3% 20
2022
Q3 		$2.29M Buy
10,475
+24
+0.2% +$5.46K 1.54% 13
2022
Q2 		$2.19M Sell
10,451
-28
-0.3% -$5.96K 1.4% 16
2022
Q1 		$2.54M Sell
10,479
-13
-0.1% -$3.14K 1.46% 13
2021
Q4 		$2.73M Buy
10,492
+54
+0.5% +$14K 1.53% 13
2021
Q3 		$2.75M Sell
10,438
-10
-0.1% -$2.73K 1.78% 7
2021
Q2 		$2.58M Buy
10,448
+20
+0.2% +$4.21K 1.68% 10
2021
Q1 		$2.02M Buy
10,428
+54
+0.5% +$10.8K 1.39% 14
2020
Q4 		$2.18M Sell
10,374
-292
-3% -$58.2K 1.56% 11
2020
Q3 		$1.83M Buy
10,666
+23
+0.2% +$4.25K 1.37% 17
2020
Q2 		$2.04M Sell
10,643
-155
-1% -$25.4K 1.66% 9
2020
Q1 		$1.59M Buy
10,798
+2
+0% +$319 1.51% 13
2019
Q4 		$1.67M Buy
+10,796
New +$1.56M 1.36% 17

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

ICW Investment Advisors's RMD Position: Q2 2026 in Review

ICW Investment Advisors reduced its ResMed (RMD) stake by 1.1% in Q2 2026, selling an estimated $28.2K and leaving 11,969 shares worth $2.33M. The position accounts for 0.82% of the portfolio, ranked #46.

ICW Investment Advisors first reported a position in RMD in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.26M in Q3 2025. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • ICW Investment Advisors held 11,969 shares of ResMed worth $2.33M as of Q2 2026.
  • ICW Investment Advisors sold 136 ResMed shares in Q2 2026, an estimated $28.2K.
  • ResMed made up 0.82% of ICW Investment Advisors's portfolio in Q2 2026, its #46 holding.
  • ICW Investment Advisors first reported a position in ResMed in Q4 2019 and has held it in 27 quarters since.
  • ICW Investment Advisors's ResMed position peaked at $3.26M in Q3 2025.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on ICW Investment Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.